Digestive Diseases and Sciences

, Volume 24, Issue 1, pp 53–64 | Cite as

A review of upper-gastrointestinal effects of the newer nonsteroidal antiinflammatory agents

  • Russell E. Pemberton
  • L. James Strand
Review Article

Abstract

Newer nonsteroidal antiinflammatory, agents (NSAIs) such as ibuprofen, naproxen, fenoprofen, and tolmetin have broadened the therapeutic choice and increased the chances of providing optimum arthritis control, but require careful assessment of the possibilities for unwanted drug effects when long-term therapy is required. A review of the literature on the gastrointestinal effects of the promising newer NSAIs, as compared with the older agents, aspirin, indomethacin, and phenylbutazone, is presented, highlighting animal toxicology and human adverse reaction surveillance data and the evidence for various suggested pathophysiological mechanisms.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wigley RA, Fowles M: Analgesics and the stomach. NZ Med J 84:104, 1976Google Scholar
  2. 2.
    Cooke, AR: The role of the mucosal barrier in drug-induced gastric ulceration and erosions. Am J Dig Dis 21:1554, 1976Google Scholar
  3. 3.
    Cooke, AR: Drugs and gastric damage. Drugs 11: 36, 1976Google Scholar
  4. 4.
    Weiss A, Pitman ER, Graham EC: Aspirin and gastric bleeding, gastroscopic observations, with review of literature. Am J Med 31:266, 1961Google Scholar
  5. 5.
    Levy M: Aspirin use in patients with major upper gastrointestinal bleeding and peptic ulcer disease. A report from the Boston collaborative drug surveillance program, Boston University Medical Center. N Engl J Med 290:1158, 1974Google Scholar
  6. 6.
    Cooke AR: Drugs and peptic ulceration. In Gastrointestinal Disease, edited by Sleisenger MH, Fordtran JS. Philadelphia, Saunders, 1973, p 642Google Scholar
  7. 7.
    Conn HO, Blitzer BL: Nonassociation of adrenocorticosteroid therapy and peptic ulcer. N Engl J Med 294:473, 1976Google Scholar
  8. 8.
    Lee P, Anderson JA, Miller J, Webb J, Buchanan WW: Evaluation of analgesic action and efficacy of antirheumatic drugs, study of 10 drugs in 684 patients with rheumatoid arthritis. J Rheumatol 3:283, 1976Google Scholar
  9. 9.
    Lewis JR: Evaluation of ibuprofen (Motrin), a new antirheumatic agent. JAMA 233:364, 1975Google Scholar
  10. 10.
    Lewis JR: New antirheumatic agents, fenoprofen calcium (Nalfon), naproxen (Naprosyn), and tolmetin sodium (Tolectin). JAMA 237:1260, 1977Google Scholar
  11. 11.
    Mills JA: Nonsteroidal anti-inflammatory drugs (in two parts) N Engl J Med 290:781 and 1002, 1974Google Scholar
  12. 12.
    Zarro BJ: New nonsteroidal anti-inflammatory drugs. Am Fam Physician 14:142, 1976Google Scholar
  13. 13.
    Alhadeff M: Sulindac. Drugs of Today 12:496, 1976Google Scholar
  14. 14.
    New Drugs for Arthritis. Med Let Drugs Ther 18:77, 1976Google Scholar
  15. 15.
    Brufen in rheumatoid arthritis. Drug Ther Bull 7:35, 1969Google Scholar
  16. 16.
    Fenoprofen. Drug Ther Bull 12:51, 1974Google Scholar
  17. 17.
    Brogden RN, Pinder RM, Sawyer PR, Speight TM, Avery GS: Naproxen: A review of its pharmacological properties and therapeutic efficacy and use. Drugs 9:326, 1975Google Scholar
  18. 18.
    Bowen R, Mayne JG, Cain JC, Bartholomew LG: Peptic ulcer in rheumatoid arthritis in relationship to steroid treatment. Mayo Clin Proc 35:537, 1960Google Scholar
  19. 19.
    Atwater EC, Mongan ES, Wieche DR, Jacox RF: Peptic ulcer in rheumatoid arthritis, a prospective study. Arch Intern Med 115:184, 1965Google Scholar
  20. 20.
    Kern F, Clark GM, Lukens JG: Peptic ulceratory occurring during therapy for rheumatoid arthritis. Gastroenterology 33:25, 1957Google Scholar
  21. 21.
    Short CL, Bauer W, Reynolds WE: Rheumatoid Arthritis. Cambridge, Harvard University Press, 1957, p. 288Google Scholar
  22. 22.
    Gibberd FD: Dyspepsia in patients with rheumatoid arthritis. Acta Rheumatol Scand 12:112, 1966Google Scholar
  23. 23.
    Sun DC, Roth SH, Mitchell CS, Englund DW: Upper gastrointestinal disease in rheumatoid arthritis. Am J Dig Dis 19:405, 1974Google Scholar
  24. 24.
    Hallesy DW, Shott LD, Hill R: Comparative toxicology of naproxen. Scand J Rheumatol (Suppl) 2:20, 1973Google Scholar
  25. 25.
    Adams SS, Bough RG, Cliffe EE, Dickinson W, Lessel B, McCullough KF, Mills RF, Nicolson JS, Williams GA: Some aspects of pharmacology, metabolism, and toxicology of ibuprofen. I. Pharmacology and Metabolism. Rheumatol Phys Med 10 (Suppl 10:9, 1970Google Scholar
  26. 26.
    Julou L, Guyonnet JC, Ducrot R, Fournel J, Pasquet J: Ketoprofen. Main pharmacological properties-Outline of toxicological and pharmacokinetic data. Scan J Rheumatol (Suppl) 14:33, 1976Google Scholar
  27. 27.
    Shriver DA, White CB, Sandor A, Rosenthale ME: A profile of the rat gastrointestinal toxicity of drugs used to treat inflammatory diseases. Toxicol Appl Pharmacol 32:73, 1975Google Scholar
  28. 28.
    Wax, J, Winder CV, Tessman DK, Stephens MD: Comparative activities, tolerances and safety of nonsteroidal anti-inflammatory agents in rats. J Pharmacol Exp Ther 192:172 1975Google Scholar
  29. 29.
    Mann NS, Sachdev A: Gastric effects of aspirin vs ketoprofen and ibuprofen. Gastroenterology 68:944, 1975Google Scholar
  30. 30.
    Mann NS, Sachdev A: Gastric effects of propoxyphene, acetaminophen, indomethacin, phenylbutazone and naproxen. J Ky Med Assoc 75:21, 1977Google Scholar
  31. 31.
    Mann NS: Gastric effects ofl-DOPA, aspirin, naproxen and Tolectin. Gastroenterology 72:1095, 1977Google Scholar
  32. 32.
    Mann NS, Mann SK: Gastric mucosal barrier, drug-induced acute erosive gastritis and stress ulcer. Am J Proctol Gastroenterol Allied Subj 28:23, 1977Google Scholar
  33. 33.
    Rainsford KD, Whitehouse MW: Non-steroid anti-inflammatory drugs: Combined assay for anti-edemic potency and gastric ulcerogenesis in the same animal. Life Sciences 21:371, 1977Google Scholar
  34. 34.
    Thorsen WB, Western D, Tanaka Y, Morrissey JF: Aspirin injury to the gastric mucosa, gastrocamera observations of the effect of pH. Arch Intern Med 121:499, 1968Google Scholar
  35. 35.
    Pierson RN, Holt, PR, Watson RM, Keating RP: Aspirin and gastrointestinal bleeding.51Chromate blood loss studies. Am J Med 31:259, 1961Google Scholar
  36. 36.
    Wanka, J, Jones LI, Wood PHN, Dixon St A J: Indomethacin in rheumatic diseases, a controlled clinical trial. Ann Rheum Dis 23:218, 1964Google Scholar
  37. 37.
    Beirne JA, Bianchine JR, Johnson PC, Wortham GF: Gastrointestinal blood loss caused by tolmetin, aspirin, and indomethacin. Clin Pharmacol Ther 16:821 1974Google Scholar
  38. 38.
    Halvorsen L, Dotevall G, Sevelius H: Comparative, effects of aspirin and naproxen on gastric mucosa. Scand J Rheumatol (Suppl) 2:43, 1973Google Scholar
  39. 39.
    Mirelli, E, Fichera G, Colombo B: Studio endoscopico sulla tolerabilita gastroduodenale di pazienti affetti da artrite reumatoide, trattati con un derivato fenilalcanoico sostituito. Minerva Med 64:2527, 1973Google Scholar
  40. 40.
    Giacovazzo M, Paoluzi P, Pallone F, Spagna G: Experienze cliniche a (doppio cieco) con un nuovo farmaco antireumatico: ibuprofen. Minerva Med 64:2558, 1973Google Scholar
  41. 41.
    Teixeira AV, Abrunhosa R, Pocas L: Observations on the gastric mucosa of rheumatic patients before and after ibuprofen administration as studied by the pentagastrin test, endoscopy, and light and electron microscopy. J Int Med Res 5:243, 1977Google Scholar
  42. 42.
    Lanza F, Royer G, Nelson R: An endoscopic evaluation of the effects of nonsteroidal anti-inflammatory drugs on the gastric mucosa. Gastrointest Endosc 21:103, 1975Google Scholar
  43. 43.
    Lanza FL, Royer GL, Nelson RS: Gastroscopic evaluation of the effects of Motrin, Indocin, Aspirin, Naprosyn, Tolectin, and placebo on gastric mucosa of normal volunteers. Arth Rheum 21:572, 1978Google Scholar
  44. 44.
    Lehtola J, Sipponen P: Gastroscopic and histological double-blind study of the effects of diclofenac sodium and naproxen on the human gastric mucosa. Scand J Rheumatol 6:97, 1977Google Scholar
  45. 45.
    Loebl DH, Craig RM, Culic DD, Ridolfo AS, Falk J, Schmid FR: Gastrointestinal blood loss. Effect of aspirin, fenoprofen, and acetaminophen in rheumatoid arthritis as determined by sequential gastroscopy and radioactive fecal markers. JAMA 237:976, 1977Google Scholar
  46. 46.
    Rahbek I: Gastroscopic, evaluation of the effect of a new antirheumatic compound, ketoprofen, on the human gastric mucosa. Scand J Rheumatol (Suppl) 14:63, 1976Google Scholar
  47. 47.
    Magnusson B, Solvell L, Arvidsson B: A comparative study of gastrointestinal bleeding during administration of ketoprofen and naproxen. Scand J Rheumatol 6:62, 1977Google Scholar
  48. 48.
    Silvoso GR, Ivey KJ, Butt JH, Lockard OO, Holt S: Incidence of gastric lesions in patients with rheumatoid arthritis and osteoarthritis on chronic aspirin therapy. Gastroenterology 74:1094, 1978Google Scholar
  49. 49.
    Silvoso GR, Ivey KJ, Butt JH, Lockard OO, Holt S: Incidence of gastric lesions in patients with rhematic diseases on chronic antiinflammatory therapy. Gastroenterology 74:1095, 1978Google Scholar
  50. 50.
    Cooke, AR, Kienzle MG: Studies of anti-inflammatory drugs and aliphatic alcohols on antral mucosa. Gastroenterology 66:56, 1974Google Scholar
  51. 51.
    Chvasta TE, Cooke AR: The effect of several ulcerogenic drugs on the canine gastric mucosal barrier. J Lab Clin Med 79:302, 1972Google Scholar
  52. 52.
    Mann NS, Sachdev AJ: Aspirin-and bile-induced acute erosive gastritis, its prevention by metiamide therapy. Arch Pathol Lab Med 101:206, 1977Google Scholar
  53. 53.
    St John DJB, Yeomans ND, Macdermott FT, Deboer WGRM: Adaptation of the gastric mucosa to repeated administration of aspirin in the rat. Am J Dig Dis 18:881, 1973Google Scholar
  54. 54.
    Lin TM, Warrick MW, Evens DC, Nash JF: Action of the anti-inflammatory agents, acetylsalicylic acid, indomethacin and fenoprofen on the gastric mucosa of dogs. Res Commun Chem Pathol Pharmacol 11:1, 1975Google Scholar
  55. 55.
    Mann NS, Mann SK: Gastric mucosal barrier, drug-induced acute erosive gastritis and stress ulcer. South Med J 70:1179, 1977Google Scholar
  56. 56.
    Mann NS: Naproxen and tolectin induced acute erosive gastritis: Its prevention by metiamide and cimetidine. Gastroenterology 72:1096, 1977Google Scholar
  57. 57.
    Murray HS, Strottman MP, Cooke AR: Effect of several drugs and gastric potential difference in man. Br Med J 1:19, 1974Google Scholar
  58. 58.
    Mackercher PA, et al.: Protective effect of cimetidine on aspirin-induced gastric mucosal damage. Ann Intern Med 87(6):676, 1977Google Scholar
  59. 59.
    MacKercher PA, Ivey KJ, Baskin WN, Krause WJ, Tatum W, Morris A: Comparison of effect of aspirin on gastric mucosa of chronic rheumatoid arthritics with normal subjects. Gastroenterology 72:1092, 1977Google Scholar
  60. 60.
    Ivey KJ, Clifton JA: Back diffusion of hydrogen ions across gastric mucosa of patients with gastric ulcer in rheumatoid arthritis. Br Med J 1:16, 1974Google Scholar
  61. 61.
    Robert A: Effect of prostaglandins on the stomach and the intestine. Prostaglandins 6:523, 1974Google Scholar
  62. 62.
    Cohen MM, Pollett JM: Treatment of gastric, erosions with E2 prostaglandins and metiamide. Gastroenterology 72:1039, 1977Google Scholar
  63. 63.
    Miller TA, Tepperman BL: Protection against aspirin-induced gastric mucosal injury by 16,16 dimethyl prostaglandin E2. Gastroenterology 72:1102, 1977Google Scholar
  64. 64.
    Fang WF, et al: Indomethacin-induced intestinal inflammation. Am J Dig Dis 22:749, 1977Google Scholar
  65. 65.
    Robinson DR, Levein L: Prostaglandin concentrations in synovial fluids in rheumatic disease. J Clin Invest 53(6):65a, 1974Google Scholar
  66. 66.
    Main IHM, Melarange R: Studies on indomethacin-induced gastric mucosal erosions and their inhibition by 16, 16 dimethyl prostaglandin E2 in the rat. Br J Pharmacol 61:507, 1978Google Scholar
  67. 67.
    Chaudhury TK, Jacobson ED: Prostaglandin cytoprotection of gastric mucosa. Gastroenterology 74:59, 1978Google Scholar
  68. 68.
    Menguy R: Gastric mucus in the gastric mucous barrier. A review. Am J Surg 117:806, 1969Google Scholar
  69. 69.
    Gerkens JF, et al: Effect of indomethacin and aspirin on gastric blood flow and acid secretion. J Pharmacol Exp Ther 203(3):646, 1977Google Scholar
  70. 70.
    Clarke AK, Barnes CG, Goodman HV, Eade AWT, Misra MN, Cochrane GM, Stoppard M: A double-blind comparison of naproxen against indomethacin in osteoarthrosis. Arzeim Forsch 25:302, 1975Google Scholar
  71. 71.
    Huskisson EC, Wojtulewski JA: Measurements of side effects of drugs. Br Med J 2:698, 1974Google Scholar
  72. 72.
    Karch FE, Lasagna L: Adverse drug reactions. A critical review. JAMA 234:1236, 1975Google Scholar
  73. 73.
    Koch-Weser J, Sellers EM, Zacest R: The ambiguity of adverse drug reactions. Eur J Clin Pharmacol 11:75, 1977Google Scholar
  74. 74.
    Blechman WJ, Schmid FR, April PA, Wilson CH Jr, Brooks CD: Ibuprofen or aspirin in rheumatoid arthritis therapy. JAMA 233:336, 1975Google Scholar
  75. 75.
    O'Brien WM: Indomethacin: A survey of clinical trials. Clin Pharmacol Ther 9:94, 1968Google Scholar
  76. 76.
    Mills, SB, Bloch M, Bruckner FE: Double-blind crossover study of ketoprofen and ibuprofen in management of rheumatoid arthritis. Br Med J 4:82, 1973Google Scholar
  77. 77.
    Rossi FA, Baroni L: A double-blind comparison between diclofenac sodium and ibuprofen in osteoarthritis. J Int Med Res 3:267, 1975Google Scholar
  78. 78.
    Dieppe PA, Burry HC, Grahame R, Perera T: Sulindac in osteoarthrosis of the hip. Rheumatol Rehabil 15:112, 1976Google Scholar
  79. 79.
    Wojtulewski JA: Fenoprofen in the treatment of osteoarthrosis. Curr Med Res Opin 2:551, 1974Google Scholar
  80. 80.
    Reynolds PMG, Whorwell PJ: A single-blind crossover comparison of fenoprofen, ibuprofen and naproxen in rheumatoid arthritis. Curr Med Res Opin 2:461, 1974Google Scholar
  81. 81.
    Huskisson EC, Woolf DL, Balme HW, Scott J, Franklin S: Four new anti-inflammatory drugs: responses and variations. Br Med J 1:1048, 1976Google Scholar
  82. 82.
    Castles JJ, Moore TL, Vaughan JA, Bolzan JA, Bolzan JA, Lee M, Lidsky MD, Caldwell JR, Ehrlich GE, Sharp JT, Kaye R: Multicenter comparison of naproxen and indomethacin in rheumatoid arthritis. Arch Intern Med 138:362, 1978Google Scholar
  83. 83.
    Boost G: Langzeit-therapie der progredient chronischen polyarthritis mit naproxen. Arzneim Forsch 25:298, 1975Google Scholar
  84. 84.
    Chalmers TM: Clinical experience with ibuprofen in the treatment of rhematoid arthritis. Ann Rheum Dis 28:513, 1969Google Scholar
  85. 85.
    Ehrlich GE, Hobbs TR, Cordrey LJ, Hamaty D: Tolmetin: Long-term therapy in patients with rheumatoid arthritis. Tolmetin, A New Nonsteroidal Anti-Inflammatory Agent. A Symposium edited by Ward JR. Princeton, Excerpta Medica, 1976, p 71Google Scholar
  86. 86.
    Sigler JW, Ridolfo AS, Bluhm GB: Comparison of benefitto-risk ratios of aspirin and fenoprofen: controlled multicenter study in rheumatoid arthritis. J Rheumatol (Suppl) 2:49, 1976Google Scholar
  87. 87.
    Huskisson EC: Long-term use of fenoprofen in rheumatoid arthritis: The therapeutic ratio. Curr Med Res Opin 2:545, 1974Google Scholar
  88. 88.
    Roth SH, Englund DW, Harris BK: Long term fenoprofen therapy in patients with rheumatoid arthritis. J Rheumatol 3:43, 1976Google Scholar
  89. 89.
    Alexander SJ: Clinical experience with naproxen in rheumatoid arthritis. Arch Intern Med 135:1429, 1975Google Scholar
  90. 90.
    Dick-Smith JB, Ibuprofen, aspirin and placebo in the treatment of rheumatoid arthritis—A double-blind clinical trial. Med J Aust 2:853, 1969Google Scholar
  91. 91.
    Roth SH, Boost G: An open trial of naproxen in rheumatoid arthritis patients with significant esophageal, gastric and duodenal lesions. J Clin Pharmacol 15:378, 1975Google Scholar
  92. 92.
    Mowat AG, Ansell BM, Gumpel JM, Hill HFH, Hill AGS, Stoppard M: Naproxen in rheumatoid arthritis, extended trial. Ann Rheum Dis 35:498, 1976Google Scholar
  93. 93.
    Cardoe N: Double-blind crossover study, of ketoprofen and phenylbutazone in patients with chronic osteoarthrosis of the hip. Rheumatol Rehab (Suppl Symposium on ketoprofen) 27, 1976Google Scholar
  94. 94.
    Holdstock DJ: Gastrointestinal bleeding: A possible association with ibuprofen. Lancet 1:541, 1972Google Scholar
  95. 95.
    Lee P, McCusker S, Allison A, Nuki G: Adverse reactions in patients with rheumatic diseases. Retrospective analysis of causes of admission and outpatient attendance in a specialist center. Ann Rheum Dis 32:565, 1973Google Scholar
  96. 96.
    Hart FD: Naproxen (Naprosyn) and gastrointestinal hemorrhage. Br Med J 1:51, 1974Google Scholar
  97. 97.
    Beck E: Naproxen (Naprosyn) and gastrointestinal hemorrhage. Br Med J 1:572, 1974Google Scholar
  98. 98.
    Hayes-Allen MC: Naproxen (Naprosyn) and gastrointestinal hemorrhage. Br Med J 1:572, 1974Google Scholar
  99. 99.
    Chabot J, Auquier L: Les effets secondaires des phenylpropionates. Therapie 31:343, 1976Google Scholar
  100. 100.
    Cardoe N: A review of long-term experience with ibuprofen, with special reference to gastric tolerance. Rheumatol Phys Med (Suppl) 10:28, 1970Google Scholar
  101. 101.
    Cuthbert MF: Adverse reactions to nonsteroidal antirheumatic drugs. Curr Med Res Opin 2:600, 1974Google Scholar
  102. 102.
    Editorial: New strategies for drug monitoring. Br Med J 1:861, 1977Google Scholar
  103. 103.
    Curtarelli G, Romussi M: Gastrointestinal bleeding under treatment with naproxen. Scand J Rheumatol 2:48, 1973Google Scholar
  104. 104.
    Arsenault A, Varady J, Lebel E, Lussier A: Effect of naproxen on gastrointestinal microbleeding following acetylsalicylate medication. J Clin Pharmacol 15:340, 1975Google Scholar
  105. 105.
    Lussier A, Arsenault A, Varady J: Comparison of gastrointestinal microbleeding in rheumatoid arthritis patients following aspirin and naproxen. Clin Pharm Ther 23(4):402, 1978Google Scholar
  106. 106.
    Brooks CD, Schlagel CA, Sekhar NC, Sobota JT: Tolerance and pharmacology of ibuprofen. Curr Ther Res 15:180, 1973Google Scholar
  107. 107.
    Thompson M, Anderson M: Studies of gastrointestinal blood loss during ibuprofen therapy. Rheumatol Phys Med (Suppl) 10:104, 1970Google Scholar
  108. 108.
    Schmid FR, Culic DD: Anti-inflammatory drugs and gastrointestinal bleeding: A comparison of aspirin and ibuprofen. J Clin Pharmacol 16:418, 1976Google Scholar
  109. 109.
    Ridolfo AS, Rubin A, Crabtree RE, Gruber CM Jr: Effects of fenoprofen and aspirin on gastrointestinal microbleeding in man. Clin Pharmacol Ther 14:226, 1973Google Scholar
  110. 110.
    Lussier A, Arsenault A: Gastrointestinal blood loss induced by ketoprofen, aspirin, and placebo. Scand J Rheumatol (Suppl) 14:73, 1976Google Scholar
  111. 111.
    Cohen A: Intestinal blood loss after a new anti-inflammatory drug, sulindac. Clin Pharmacol Ther 20:238, 1976Google Scholar
  112. 112.
    Bowers DE, Dyer HR, Fosdick WM, Keller KE, Rosenberg AL, Sussman P, Vancil ME: Naproxen in rheumatoid arthritis, a controlled trial. Ann Intern Med 83:470, 1975Google Scholar
  113. 113.
    Hill HFH, Hill AGS, Mowat AG, Ansell BM, Matthews JA, Seifert MH, Gumpel JM, Christie GA: Naproxen, a new nonhormonal anti-inflammatory agent. Ann Rheum Dis 33:12, 1974Google Scholar
  114. 114.
    Diamond H, Alexander S, Kuzell W, Lussier A, Odone D, Tompkins R: A multicenter double-blind crossover comparison study of naproxen and aspirin in patients with rheumatoid arthritis. Scand J Rheumatol (Suppl) 2:171, 1973Google Scholar
  115. 115.
    Cochrane GM: A double-blind comparison of naproxen with indomethacin in osteoarthritis Scand J Rheumatol (Suppl) 2:89, 1973Google Scholar
  116. 116.
    Kogstad O: A double-blind crossover study of naproxen and indomethacin in patients with rheumatoid arthritis. Scand J Rheumatol (Suppl) 2:159, 1973Google Scholar
  117. 117.
    D'Omezon Y: Etude des cliniciens Francais sur l'action du naproxene dans la P.C.E. Scand J Rheumatol (Suppl) 2:164, 1973Google Scholar
  118. 118.
    Kageyama T: Clinical evaluation of naproxen in the treatment of osteoarthritis—Double-blind crossover trial. Scand J Rheumatol (Suppl) 2:94, 1973Google Scholar
  119. 119.
    Helby-Peterson P, Ibfelt H, Rossel, I: A double-blind crossover comparison of naproxen and placebo in rheumatoid arthritis. Scand J Rheumatol (Suppl) 2:145, 1973Google Scholar
  120. 120.
    Dornan J, Reynolds WJ: Comparison of ibuprofen and acetylsalicylic acid in the treatment of rheumatoid arthritis. Can Med Assoc J 110:1370, 1974Google Scholar
  121. 121.
    Brooks CD, Schmid FR, Biundo J, Blau S, Gonzalez-Alcover R, Gowans JDC, Hurd E, Partridge REH, Tarpley EL: Ibuprofen and aspirin in the treatment of rheumatoid arthritis, a comparative double-blind trial. Rheumatol Phys Med 10:48, 1970Google Scholar
  122. 122.
    Huskisson EC, Shenfield GM, Taylor RT, Hart FD: A new look at ibuprofen. Rheumatol Phys Med (Suppl) 10:88, 1970Google Scholar
  123. 123.
    Royer GL Jr, Moxley TE, Hearron MS, Miyara A, Donovan JF: A six-month double-blind trial of ibuprofen and indomethacin in osteoarthritis. Curr Ther Res 17:234, 1975Google Scholar
  124. 124.
    Boardman PL, Nuki G, Hart FD: Ibuprofen in the treatment of rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 26:560, 1967Google Scholar
  125. 125.
    Fries JF, Britton MC: Fenoprofen calcium in rheumatoid arthritis. A controlled double-blind crossover evaluation. Arthritis Rheum 16:629, 1973Google Scholar
  126. 126.
    Gum OB: Fenoprofen in rheumatoid arthritis: a controlled crossover multicenter study. J Rheumatol (Suppl) 2:26, 1976Google Scholar
  127. 127.
    Brooke JW: Fenoprofen therapy in large-joint osteoarthritis: Double-blind comparison with aspirin and longterm experience. J Rheumatol (Suppl) 2:71, 1976Google Scholar
  128. 128.
    Huskisson EC, Wojtulewski JA, Berry H, Scott J, Hart FD, Balme HW: Treatment of rheumatoid arthritis with fenoprofen: comparison with aspirin. Br Med J 1:176, 1974Google Scholar
  129. 129.
    Diamond HS: Double-blind crossover study of fenoprofen and aspirin in osteoarthritis. J Rheumatol (Suppl) 2:67, 1976Google Scholar
  130. 130.
    Zuckner J, Auclair RJ: Fenoprofen calcium therapy in rheumatoid arthritis. J Rheumatol (Suppl) 2:18, 1976Google Scholar
  131. 131.
    Davis JD, Turner RA, Collins RL, Ruchte IR, Kaufman JS: Fenoprofen, aspirin and gold induction in rheumatoid arthritis. Clin Pharm Ther 21:52, 1977Google Scholar
  132. 132.
    Zutshi D, Mason M: Ketoprofen in rheumatoid arthritis: Its tolerance and therapeutic effect. Scand J Rheumatol (Suppl) 14:77, 1976Google Scholar
  133. 133.
    Fossgreen J, Kirchheiner B, Petersen FO, Tophog E, Zachariae E: Clinical evaluation of ketoprofen in rheumatoid arthritis. Double-blind crossover comparison with indomethacin. Scand J Rheumatol (Suppl) 14:93, 1976Google Scholar
  134. 134.
    Zutshi DW, Stern D, Bloch M, Mason, RN: Ketoprofen: double-blind crossover study with indomethacin in patients with rheumatoid arthritis. Rheumatol Rehabil 13:10, 1974Google Scholar
  135. 135.
    Caroit M, Forette B, Hubault A, Pasquier P: Double-blind study of ketoprofen against a placebo in osteoarthritis of the hip. Scand J Rheumatol (Suppl) 14:123, 1976Google Scholar
  136. 136.
    Famaey JP, Colinet E: A double-blind trial of ketoprofen in the treatment of osteoarthritis of the hip. Scand J Rheumatol (Suppl) 14:129, 1976Google Scholar
  137. 137.
    Huskisson EC, Berry H, Scott J, Balme HW: Tolectin for rheumatoid arthritis. Rheumatol Rehabil 13:132, 1974Google Scholar
  138. 138.
    Berkowitz SS, Bernhard G, Bilka PJ, Blechman WJ, Marchesano JM, Rosenthal M, Wortham GF: Tolmetin versus placebo for the treatment of rheumatoid arthritis: A sequential double-blind clinical trial. Curr Ther Res 16:442, 1974Google Scholar
  139. 139.
    Solomon L, Abrams G: Voltaren in the treatment of rheumatoid arthritis. S Afr Med J 48:949, 1974Google Scholar
  140. 140.
    Durrigl T, Vitaus M, Pucar I, Miko M: Diclofenac sodium (Voltaren): Results of a multicenter comparative trial in adult-onset rheumatoid arthritis. J Int Med Res 3:139, 1975Google Scholar
  141. 141.
    Appelboom T, Famaey JP: Le voltaren dans le traitment de la periarthrite scapulo-humerale et des lombalgies. Bruxelles Medical 56:49, 1976Google Scholar
  142. 142.
    Kirchheiner B, Trang L, Wollheim FA: Diclofenac sodium (Voltaren) in rheumatoid arthritis: A double-blind comparison with indomethacin and placebo. Int J Clin Pharmacol 13:292, 1976Google Scholar
  143. 143.
    Reynolds PMG, Rhymer AR, MacLeod MM, Buchanan WW: Comparison of sulindac and aspirin in rheumatoid arthritis. Curr Med Res Opin 4:485, 1977Google Scholar
  144. 144.
    Rosekrans PCM, Stoyanova M, Mak M, Cats A, Steiner FJ: A comparative study of sulindac (MK-231), aspirin and placebo in coxarthritis: Some problems related to the clinical evaluation of analgesic, anti-inflammatory drugs. Pharmatherapeutica 1:52, 1976Google Scholar

Copyright information

© Digestive Disease Systems, Inc 1979

Authors and Affiliations

  • Russell E. Pemberton
    • 1
    • 2
  • L. James Strand
    • 1
  1. 1.Syntex LaboratoriesPalo Alto
  2. 2.University of California Medical CenterSan Francisco

Personalised recommendations